ID | Description | P value | P adjust |
---|---|---|---|
GO:0004896 | cytokine receptor activity | 1.64E-11 | 6.31E-09 |
GO:0001637 | G protein-coupled chemoattractant receptor activity | 4.05E-08 | 3.23E-06 |
GO:0004950 | chemokine receptor activity | 4.05E-08 | 3.23E-06 |
GO:0019955 | cytokine binding | 4.21E-08 | 3.23E-06 |
GO:0016493 | C-C chemokine receptor activity | 1.65E-07 | 9.05E-06 |
GO:0019957 | C-C chemokine binding | 2.54E-07 | 1.30E-05 |
GO:0019956 | chemokine binding | 3.92E-07 | 1.88E-05 |
GO:0023023 | MHC protein complex binding | 6.72E-07 | 3.04E-05 |
GO:0042287 | MHC protein binding | 1.33E-06 | 5.67E-05 |
GO:0032395 | MHC class II receptor activity | 2.54E-05 | 0.001027582 |
GO:0030246 | carbohydrate binding | 0.000143695 | 0.004598232 |
GO:0001608 | G protein-coupled nucleotide receptor activity | 0.000175825 | 0.005193614 |
GO:0045028 | G protein-coupled purinergic nucleotide receptor activity | 0.000175825 | 0.005193614 |
GO:0030695 | GTPase regulator activity | 0.000508907 | 0.012607749 |
KEGG:hsa04662 | B cell receptor signaling pathway | 4.67E-12 | 1.85E-10 |
KEGG:hsa04062 | Chemokine signaling pathway | 2.79E-09 | 4.07E-08 |
KEGG:hsa04660 | T cell receptor signaling pathway | 1.36E-07 | 1.45E-06 |
KEGG:hsa04650 | Natural killer cell mediated cytotoxicity | 3.92E-07 | 4.02E-06 |
KEGG:hsa04060 | Cytokine-cytokine receptor interaction | 1.07E-06 | 1.03E-05 |
KEGG:hsa04064 | NF-kappa B signaling pathway | 0.000577911 | 0.00390442 |
KEGG:hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 0.001387015 | 0.008934958 |
KEGG:hsa05231 | Choline metabolism in cancer | 0.008939182 | 0.047618336 |